Nephro Care logo

Nephro Care

NEPHROCARE NSE
₹86.50 2.65 (3.16%)
Market Cap
₹143 Cr
P/E
72.08

Key Fundamentals

SMEHospitalsHealthcare Services
Market Cap
₹143 Cr
P/E (TTM)
72.08
EBITDA
₹9.90 Cr
Return on Equity
5.92%
Debt to Equity
0
Book Value
₹34.49
EPS (TTM)
₹1.20
52W High
₹156.35
52W Low
₹50.05

Price-based figures as of 13 Oct 2026, 15:28 IST · TTM

Peer Comparison

Healthcare › Healthcare Services › Hospitals › Hospital

Apollo Hospitals
₹7,875.0054.191,13,230 Cr11.940.25%20.08%19.79%26,675 Cr2,171 Cr
Max Healthcare Institute
₹861.0057.4883,802 Cr7.800.23%13.42%12.70%8,879 Cr1,457 Cr
Aster DM Healthcare
₹689.85112.1760,132 Cr14.290.43%8.84%9.71%5,006 Cr363 Cr
Fortis Healthcare
₹756.4054.5057,105 Cr5.770.13%10.47%12.13%9,607 Cr1,070 Cr
Narayana Hrudayalaya
₹1,687.3042.2534,482 Cr7.600.26%17.85%11.39%9,185 Cr816 Cr
Global Health
₹1,280.2061.8834,421 Cr8.690.04%13.91%15.05%4,800 Cr552 Cr
Krishna Institute of Medical Sciences
₹709.95140.5829,818 Cr7.960.00%9.46%8.23%4,252 Cr194 Cr
Dr Agarwals Health Care
₹471.35100.5014,943 Cr7.380.00%7.93%9.74%2,245 Cr185 Cr
Rainbow Childrens Medicare
₹1,216.6043.3012,357 Cr7.400.28%16.92%16.84%1,857 Cr291 Cr
Park Medi World
₹235.5535.5310,174 Cr5.060.00%13.00%18.10%1,789 Cr298 Cr
Nephro Care (this company)
₹86.5072.08143 Cr2.510.00%5.92%8.35%74 Cr2 Cr
Median 11 companies₹756.4057.4834,421 Cr7.600.13%13.00%12.13%4,800 Cr363 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100. How it works →

As of 2026-10-12
v2.0.0
60 Good
Overall score
Data confidence 100/100

Category scores

Quality Strong 70
Returns, margins, earnings quality 22%
Valuation Poor 27
Cheap vs sector & own history 24%
Growth Strong 99
Sales & profit trajectory 9%
Financial Health Strong 85
Solvency, leverage, coverage 9%
Momentum Good 56
Trend strength, vol-adjusted 12%
Ownership Average 55
FII/DII/promoter flows 24%

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company is almost debt free.

Weaknesses

2
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 9.53% over last 3 years.

Technical Indicators

Oscillators

BearishNeutralBullish

Bullish

Bearish
2
Neutral
4
Bullish
3

Overall

BearishNeutralBullish

Bearish

Bearish
10
Neutral
4
Bullish
5

Moving Averages

BearishNeutralBullish

Bearish

Bearish
8
Neutral
0
Bullish
2

Growth Rate

Revenue Growth
93% higher than 3Y

change over 1 year

Net Income Growth
24% higher than 3Y

change over 1 year

Cash Flow Change
110%

change over 1 year

EBITDA Margin Change
—

Operating margin 12.4% · Jun 2026

Quarterly Results

Particulars Jun 2025Dec 2025Mar 2026Jun 2026
Sales
17.33
22.66
26.75
29.19
Expenses
16.73
20.75
24.73
25.57
Operating Profit
0.6
1.91
2.02
3.62
OPM %
3.46%
8.43%
7.55%
12.4%
Other Income
0.05
0.08
0.83
0.22
Interest
0.14
0.03
-0.01
0.03
Depreciation
1.16
1.4
1.56
1.19
PBT
-0.65
0.56
1.3
2.62
Tax %
0%
25%
23.08%
38.17%
Net Profit
-0.65
0.42
1
1.61
EPS (₹)
-0.39
0.25
0.61
0.98
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
0.54
1.82
3.42
17.09
27.23
46.03
88.74
Expenses
0.52
1.67
3.28
13.66
20.76
40.16
80.42
Operating Profit
0.02
0.15
0.14
3.43
6.47
5.87
8.32
OPM %
3.7%
8.24%
4.09%
20.07%
23.76%
12.75%
9.38%
Other Income
0.01
0.01
-0.01
0
0.28
1.53
1.55
Interest
0.04
0.03
0.02
0.07
0.09
0.11
0.16
Depreciation
0
0.01
0.11
0.78
0.53
2.46
5.07
PBT
-0.01
0.12
0
2.58
6.13
4.83
4.64
Tax %
0%
25%
—
7.75%
28.06%
24.64%
27.37%
Net Profit
-0.01
0.09
-0.01
2.37
4.41
3.64
3.37
EPS (₹)
-10
90
-0.2
47.4
3.71
2.21
2.04
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
0.01
0.01
0.5
0.5
11.9
16.49
16.49
Reserves
0.07
0.01
0
2.03
3.12
37
40.37
Borrowings
0.4
0.69
2.54
2.48
0
0
0
Other Liabilities
0.3
0.42
1.6
3.25
5.94
14.79
15.81
Total Liabilities
0.78
1.13
4.64
8.26
20.96
68.28
72.67
Fixed Assets
0.45
0.06
1.39
3.01
4.74
31.48
34.01
CWIP
0
0.45
1.9
0
0.86
0.61
0.53
Investments
0.24
0
0
2
6.51
18.58
11.81
Other Assets
0.09
0.62
1.35
3.25
8.85
17.61
26.32
Total Assets
0.78
1.13
4.64
8.26
20.96
68.28
72.67
Figures in ₹ Crores

Cash Flow

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
—
0.23
0.62
4.12
0.91
7.24
2.21
Investing
—
-0.06
-2.81
-2.33
-7.54
-39.83
-0.48
Financing
—
0.28
2.32
-0.08
5.6
35.96
0
Net Cash Flow
—
0.44
0.13
1.71
-1.03
3.37
1.73
Free Cash Flow
—
0.16
-2.28
3.62
-2.38
-22.56
-5.59
CFO/OP
—
133
493
121
50
141
48
Figures in ₹ Crores

Ratios

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
0
0
20.28
0.85
2.01
25.61
24.84
Inventory Days
—
8.83
41.93
35.25
14.07
34.38
31.68
Days Payable
—
94.19
113
69.03
75.17
107
92.84
Cash Conversion Cycle
0
-85.36
-51.24
-32.93
-59.09
-47.33
-36.31
Working Capital Days
-169
-88.24
-125
-56.81
-36.86
-51.15
-4.07
ROCE %
—
25.21%
1.6%
65.84%
60.41%
11.27%
7.9%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Nephro Care insights

55 extracted metrics + investor summaries across FY20–FY27.

Log in — free

Shareholding Pattern

FIIs0.96%Promot.61.71%DIIs1.29%Others5.69%Public30.34%As ofJun 2026

Documents

Frequently Asked Questions about Nephro Care

What does Nephro Care India Ltd do?
Incorporated in 2014, Nephro Care India Ltd is a healthcare provider that specializes in the treatment of kidney- related diseases[1]
Where is Nephro Care India Ltd (NEPHROCARE) listed?
Nephro Care India Ltd trades as NEPHROCARE on the NSE.
Which sector does Nephro Care India Ltd belong to?
Nephro Care India Ltd is classified under the Healthcare Services sector, in the Hospitals industry.
What is the market capitalisation of Nephro Care India Ltd?
Nephro Care India Ltd has a market capitalisation of ₹142.61 Cr as of 13 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Nephro Care India Ltd?
Nephro Care India Ltd trades at a PE ratio of 72.08 as of 13 Oct 2026, on earnings per share of ₹1.2, against a book value of ₹34.49 per share.
What is the 52-week high and low of Nephro Care India Ltd?
Over the last 52 weeks Nephro Care India Ltd has traded between ₹50.05 and ₹156.35 as of 13 Oct 2026.
What is the Return on Equity (ROE) of Nephro Care India Ltd?
Nephro Care India Ltd reported a return on equity of 5.92%. Its debt-to-equity ratio is 0.00.

Company Information

Incorporated in 2014, Nephro Care India Ltd is a healthcare provider that specializes in the treatment of kidney- related diseases[1]

Website nephrocareindia.com
Listed 2024-07-05
Face Value ₹ 10
Shares Outstanding 1,64,86,400

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/NEPHROCARE.md for Nephro Care India Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More in Healthcare Services → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List